Miraculins Announces Change to Board of Directors
22 April 2014 - 1:00AM
Marketwired Canada
Miraculins Inc. (TSX VENTURE:MOM) (the "Company"), a medical diagnostic company
focused on acquiring, developing and commercializing diagnostic tests and risk
assessment technologies for unmet clinical needs, announces today that David
Eichler has stepped down from the Company's Board of Directors.
"The Board wishes to thank David for his effective contributions during his
tenure as a director," said Harry Bloomfield Q.C., Chair of the Miraculins
Board.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
FOR FURTHER INFORMATION PLEASE CONTACT:
Miraculins Inc.
Christopher J. Moreau
President & CEO
204-477-7599
204-453-1546 (FAX)
info@miraculins.com
www.miraculins.com
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über (TSX Venture Börse): 0 Nachrichtenartikel
Weitere Miraculins Inc. News-Artikel